AIM
RARE icon

Ada Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Ada Investment Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$376K Buy
3,353
+1,074
+47% +$107K 0.25% 125
2015
Q3 		$219K Buy
+2,279
New +$261K 0.11% 372

Other funds holding RARE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ada Investment Management's RARE Position: Q4 2015 in Review

Ada Investment Management increased its Ultragenyx Pharmaceutical (RARE) stake by 47% in Q4 2015, buying an estimated $107K and bringing the position to 3,353 shares worth $376K. The position accounts for 0.25% of the portfolio, ranked #125.

Ada Investment Management first reported a position in RARE in Q3 2015 and has held it in 2 quarters since. 171 funds tracked by Wall St. Rank hold RARE as of Q4 2015.

  • Ada Investment Management held 3,353 shares of Ultragenyx Pharmaceutical worth $376K as of Q4 2015.
  • Ada Investment Management bought 1,074 Ultragenyx Pharmaceutical shares in Q4 2015, an estimated $107K.
  • Ultragenyx Pharmaceutical made up 0.25% of Ada Investment Management's portfolio in Q4 2015, its #125 holding.
  • Ada Investment Management first reported a position in Ultragenyx Pharmaceutical in Q3 2015 and has held it in 2 quarters since.
  • 171 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.